Sinusitis (also called rhino sinusitis) is the name of the condition in which the lining of your sinuses becomes inflamed. The sinuses are air spaces behind the bones of the upper face, between the eyes and behind the forehead, nose and cheeks.
Intersect ENT announced that the FDA has approved Propel mini (mometasone furoate), a localized steroid-releasing product for patients with chronic sinusitis. The Propel mini is a smaller version of Propel that is inserted by a physician following endoscopic sinus surgery. The implant expands to prop open the sinus, gradually delivers an advanced steroid with anti-inflammatory properties directly to the sinus lining, and then dissolves into the body.